CCNE1 AMPLIFICATION AND OVEREXPRESSION CHARACTERIZE OVARIAN CLEAR CELL CARCINOMA BUT NOT OVARIAN ENDOMETRIOID CARCINOMA

被引：0
|
作者：
Ayhan, A. [1 ]
Ogawa, H. [2 ]
Wu, R. C. [3 ,4 ]
Sugimura, H. [5 ]
Wang, T. L. [6 ]
Shih, I. M. [7 ]
机构：
[1] Hamamatsu Univ Sch Med, Johns Hopkins Med Inst, Pathol, Seirei Mikatahara Hosp, Hamamatsu, Shizuoka 4313192, Japan
[2] Seirei Mikatahara Hosp, Pathol, Hamamatsu, Shizuoka, Japan
[3] Chang Gung Mem Hosp, Pathol, Taoyuan, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[5] Hamamatsu Univ Sch Med, Pathol, Hamamatsu, Shizuoka 4313192, Japan
[6] Johns Hopkins Med Inst, Pathol, Baltimore, MD 21205 USA
[7] Johns Hopkins Med Inst, Pathol Gynecol Obstet Oncol, Baltimore, MD 21205 USA
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-1413
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [1] CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma
    Ayhan, Ayse
    Ogawa, Hiroshi
    Bahadirli-Talbott, Asli
    Wu, Ren-Chin
    Sugimura, Haruhiko
    Wang, Tian-Li
    Shih, Ie-Ming
    [J]. MODERN PATHOLOGY, 2015, 28 : 273A - 274A
  • [2] CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma
    Ayhan, Ayse
    Ogawa, Hiroshi
    Bahadirli-Talbott, Asli
    Wu, Ren-Chin
    Sugimura, Haruhiko
    Wang, Tian-Li
    Shih, Ie-Ming
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 273A - 274A
  • [3] CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis
    Ayhan, Ayse
    Kuhn, Elisabetta
    Wu, Ren-Chin
    Ogawa, Hiroshi
    Bahadirli-Talbott, Ash
    Mao, Tsui-Lien
    Sugimura, Haruhiko
    Shih, Ie-Ming
    Wang, Tian-Li
    [J]. MODERN PATHOLOGY, 2017, 30 (02) : 297 - 303
  • [4] CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kobayashi, Hiroshi
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [5] CCNE1 Is a Novel Synthetic Lethal Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
    Kawahara, Naoki
    Yamada, Yuki
    Kawaguchi, Ryuji
    [J]. CANCER SCIENCE, 2023, 114 : 1845 - 1845
  • [6] Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma With Clear Cell Change, and Clear Cell Carcinoma
    Lim, Diana
    Ip, Philip P. C.
    Cheung, Annie N. Y.
    Kiyokawa, Takako
    Oliva, Esther
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (08) : 1061 - 1069
  • [7] An Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma with Clear Cell Change and Clear Cell Carcinoma
    Lim, D.
    Ip, P.
    Cheung, A.
    Kiyokawa, T.
    Oliva, E.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 293A - 293A
  • [8] An Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma with Clear Cell Change and Clear Cell Carcinoma
    Lim, D.
    Ip, P.
    Cheung, A.
    Kiyokawa, T.
    Oliva, E.
    [J]. MODERN PATHOLOGY, 2014, 27 : 293A - 293A
  • [9] The role of CCNE1 amplification in refractory ovarian and endometrial cancer
    Park, J. A.
    Bethany, B.
    Frimer, M.
    Cheng, K.
    John, V. S.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 216 - 216
  • [10] Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma
    Wang, Yiying
    Mang, Maggie
    Wang, Yue
    Wang, Lijie
    Klein, Robert
    Kong, Beihua
    Zheng, Wenxin
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (03): : 869 - 879
12345